Pfizer buys Array Biopharma for $11.4 billion, sending shares of Array up 57%. Ron Gross analyzes the acquisition spree among big pharmaceutical companies. Target has a massive outage over the weekend, but we still have a few more questions about why. Plus, we dip into the Fool Mailbag and discuss the latest news from Papa John’s.

Thanks to Sprout Social for supporting Motley Fool. To learn how your brand can create real connection, visit sproutsocial.com/fool today.

Lululemon athletica and RH both rise on strong 1st-quarter reports, but MFAM Funds portfolio manager Bill Barker is more bullish on one than the other.  Plus, Suntrust and BB&T unveil the name of their recently-merged $66 billion bank and it’s……Truist??? We share our reactions, as well as the business case against the new name. (Tangents include competitive yoga, why the Stanley Cup is the best trophy in North American sports, and how the classic movie “This Is Spinal Tap” relates to the 6th-largest bank in the U.S.)

Dave & Buster’s misses quarterly earnings by one penny and shares drop 22%. Seth Jayson analyzes why a new multi-year low isn’t enough to get him interested in this stock. Plus, we discuss Tesla’s annual meeting, TheStreet.com leaving the public markets, and a preview of Lululemon athletica’s upcoming earnings report.

Get $50 off your first job post at www.LinkedIn.com/Fool.

Casey’s General Stores hits a new all-time high after blowout 4th-quarter earnings.  Bill Mann analyzes how Casey’s is quietly a threat to McDonald’s. Plus, we discuss Foxconn’s potential move out of China, Wells Fargo’s challenge to find a new CEO, and highlights from FoolFest 2019.

United Technologies and Raytheon combine forces to form the second largest aerospace and defense company in the U.S. Salesforce.com buys Tableau Software. Video conferencing technology company Zoom continues its rise. And Canadian cannabis producer Tilray surges on good news.

Get $50 off your first job post at www.LinkedIn.com/Fool.